Home » Topics » BioWorld Science

BioWorld Science
RSS

Corvas discloses thrombin inhibitors

Aug. 16, 1996

Favorable safety review for Neuprex

Aug. 16, 1996

Pilot study results reported for CytoTAb

Aug. 16, 1996

PLC Systems granted patent integral to Heart Laser technology

Aug. 16, 1996

Cardiac tropinin provides accurate detection of MI

Aug. 16, 1996

Zynaxis to develop Zyn-Linker form of heparin under SBIR grant

Aug. 16, 1996

Kanebo reports Na+/H+ exchange inhibitors

Aug. 16, 1996

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

Pseudostat enters phase II in CF patients

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...